Skip to content
HowShorted

Cabaletta Bio, Inc. short interest in 2024

In 2024, Cabaletta Bio, Inc.'s disclosed short interest ran from 14.98% of shares outstanding on 12 Jan 2024 to 12.32% on 31 Dec 2024, a change of -2.66 percentage points. The year's high was 21.25% on 30 Apr 2024 and its low 7.36% on 15 Nov 2024, averaging 14.58% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.63 days on 31 May 2024. Full history: Cabaletta Bio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Cabaletta Bio, Inc. in 2024

2024 in figures

Start of year
14.98% (12 Jan 2024)
End of year
12.32% (31 Dec 2024)
Change
-2.66 pp
High
21.25% (30 Apr 2024)
Low
7.36% (15 Nov 2024)
Average
14.58%
Highest days to cover
11.63 (31 May 2024)
SEC filings marked
9

Every report in 2024

Cabaletta Bio, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 202414.98%8.02results (8-K)
31 Jan 202414.91%8.05
15 Feb 202415.94%6.45
29 Feb 202416.36%11.47
15 Mar 202414.70%6.51
28 Mar 202417.62%7.2510-K filed, results (8-K)
15 Apr 202420.47%10.52
30 Apr 202421.25%6.12
15 May 202418.87%8.1610-Q filed, results (8-K)
31 May 202419.63%11.63
14 Jun 202419.59%6.52
28 Jun 202414.87%3.19
15 Jul 202415.57%9.46
31 Jul 202418.19%10.45
15 Aug 202412.86%3.9510-Q filed, results (8-K)
30 Aug 202413.08%6.73
13 Sep 202413.09%8.65
30 Sep 202410.90%4.59
15 Oct 20247.74%4.88
31 Oct 20247.59%3.93
15 Nov 20247.36%3.3010-Q filed, results (8-K)
29 Nov 20249.22%1.00
13 Dec 202412.74%1.31
31 Dec 202412.32%3.94

See also: Cabaletta Bio, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.